Molecular Mechanisms Controlling KIR Genes in NK Cells
Molecular Mechanisms Controlling KIR Genes in NK Cells
批准号:
7188084
负责人:
Charles T. Lutz
金额:
$35.47万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
已结题
起止时间:
2003-09-01 至 2009-02-28
关键词:
AllelesBindingCell LineCellsClassCollaborationsCommunicable DiseasesComplexCongenital AbnormalityControl LocusCytomegalovirusDataDevelopmentElementsEnhancersFamilyGene ExpressionGene Expression RegulationGene FamilyGenesGenetic TranscriptionGoalsHematopoiesisHistone DeacetylaseHumanImmuneImmunityImmunoglobulinsIndividualInsulator ElementsInterleukin-15Interleukin-2Interleukin-3Interleukin-7InternationalKiller CellsKnowledgeLaboratoriesLeadLigandsLymphocyteMalignant NeoplasmsMethylationModelingMolecularMolecular BiologyNatural Killer CellsNormal CellNumbersPrincipal InvestigatorProteinsRangeReagentReceptor GeneRecruitment ActivityRegulationReportingResearchResearch PersonnelResearch TechnicsSignal TransductionSiteStem Cell FactorStromal CellsT-LymphocyteTestingTissue-Specific Gene ExpressionTrans-ActivatorsUniversitiesWorkcancer cellcancer immunotherapycancer therapycell killingcis acting elementcytokineexpectationimprovedinnovationinsightleukemia/lymphomapromoterreceptorreceptor expression
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Natural killer (NK) cells use killer cell immunoglobulin-like receptors (KIR) to distinguish normal cells from infected and malignant cells. NK cells express an apparently random assortment of KIR genes. Our LONG RANGE GOAL is to use NK cells to treat cancer and infectious diseases. Our CURRENT OBJECTIVE is to identify how developing NK cells initiate and then maintain selective KIR gene expression. Supported by strong preliminary data, our CENTRAL HYPOTHESIS is that promoter methylation controls locus-specific and allele-specific KIR gene expression. The RATIONALE for the proposed research is that understanding KIR gene regulation could lead to effective immunotherapy of cancer and infectious diseases. Furthermore, our research will test the central paradigm of tissue-specific gene expression. The proposed research is a COLLABORATION between investigators at two universities. The principal investigator has an established record of research in NK ceils, immune recognition of HLA class I molecules, and molecular biology. The other investigators are leaders in gene expression control and in human NK cell development. The collaboration will produce a synergistic effect that is not easily matched by a single investigator. Our SPECIFIC AIMS are to 1. Test the molecular mechanisms of KIR gene expression control. 2. Define cis acting elements and trans-acting factors that control KIR gene expression. 3. Elucidate how developing NK cells initiate selective KIR gene expression. Our approach is INNOVATIVE. We have produced unique new data and we will combine several cutting-edge research techniques to rigorously test our hypotheses. It is our EXPECTATION that 1) we will develop a clear understanding of how NK cells maintain stable KIR expression; 2) we will define several important cis-acting elements and trans-acting factors that regulate KIR transcription; 3) we will identify what signals developing NK cells use to initiate KIR gene expression. Our results will be highly SIGNFICANT, because they will be essential for understanding how NK cells distinguish normal from aberrant cells. Of broader significance, elucidation of KIR gene expression control will provide an important model for gene choice in development and offer insights into birth defects and cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Muscle, Fat and NK Lymphocytes in Aging
-
批准号:8517537
-
项目类别:
-
资助金额:$17.54万
-
财政年份:2012
-
负责人:Charles T. Lutz
-
依托单位:
Muscle, Fat and NK Lymphocytes in Aging
-
批准号:8384461
-
项目类别:
-
资助金额:$22.28万
-
财政年份:2012
-
负责人:Charles T. Lutz
-
依托单位:
Natural Killer Subset Senescence and Clonality in Aging
-
批准号:7286019
-
项目类别:
-
资助金额:$5.83万
-
财政年份:2006
-
负责人:Charles T. Lutz
-
依托单位:
Natural Killer Subset Senescence and Clonality in Aging
-
批准号:7143838
-
项目类别:
-
资助金额:$6.01万
-
财政年份:2006
-
负责人:Charles T. Lutz
-
依托单位:
Immune Senescence: Molecular Mechanisms, Diets & Stress
-
批准号:7040769
-
项目类别:
-
资助金额:$0.24万
-
财政年份:2004
-
负责人:Charles T. Lutz
-
依托单位:
Molecular Mechanisms Controlling NK Receptors
-
批准号:7729934
-
项目类别:
-
资助金额:$37.48万
-
财政年份:2003
-
负责人:Charles T. Lutz
-
依托单位:
Molecular Mechanisms Controlling KIR Genes in NK Cells
-
批准号:6897731
-
项目类别:
-
资助金额:$5.87万
-
财政年份:2003
-
负责人:Charles T. Lutz
-
依托单位:
Molecular Mechanisms Controlling NK Receptors
-
批准号:8224060
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2003
-
负责人:Charles T. Lutz
-
依托单位:
Molecular Mechanisms Controlling NK Receptors
-
批准号:7932892
-
项目类别:
-
资助金额:$37.46万
-
财政年份:2003
-
负责人:Charles T. Lutz
-
依托单位:
Molecular Mechanisms Controlling KIR Genes in NK Cells
-
批准号:7032231
-
项目类别:
-
资助金额:$43.57万
-
财政年份:2003
-
负责人:Charles T. Lutz
-
依托单位:
Molecular Mechanisms Controlling KIR Genes in NK Cells
-
批准号:6793709
-
项目类别:
-
资助金额:$35.31万
-
财政年份:2003
-
负责人:Charles T. Lutz
-
依托单位:
Molecular Mechanisms Controlling KIR Genes in NK Cells
-
批准号:6575509
-
项目类别:
-
资助金额:$18.1万
-
财政年份:2003
-
负责人:Charles T. Lutz
-
依托单位:
Molecular Mechanisms Controlling KIR Genes in NK Cells
-
批准号:6845105
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2003
-
负责人:Charles T. Lutz
-
依托单位:
Molecular Mechanisms Controlling NK Receptors
-
批准号:8321445
-
项目类别:
-
资助金额:$36.79万
-
财政年份:2003
-
负责人:Charles T. Lutz
-
依托单位:
MHC CLASS I STRUCTURES CONTROLLING NK CELLS
-
批准号:2132274
-
项目类别:
-
资助金额:$17.81万
-
财政年份:1995
-
负责人:Charles T. Lutz
-
依托单位:
MHC CLASS I STRUCTURES CONTROLLING NK CELLS
-
批准号:2733740
-
项目类别:
-
资助金额:$19.56万
-
财政年份:1995
-
负责人:Charles T. Lutz
-
依托单位:
MHC CLASS I STRUCTURES CONTROLLING NK CELLS
-
批准号:2443683
-
项目类别:
-
资助金额:$18.89万
-
财政年份:1995
-
负责人:Charles T. Lutz
-
依托单位:
MHC CLASS I STRUCTURES CONTROLLING NK CELLS
-
批准号:2132273
-
项目类别:
-
资助金额:$16.18万
-
财政年份:1995
-
负责人:Charles T. Lutz
-
依托单位:
NK CELL RECEPTOR RECOGNITION OF ORAL CANCERS
-
批准号:6806782
-
项目类别:
-
资助金额:$28.11万
-
财政年份:1995
-
负责人:Charles T. Lutz
-
依托单位:
NK CELL RECEPTOR RECOGNITION OF ORAL CANCERS
-
批准号:6195816
-
项目类别:
-
资助金额:$30.51万
-
财政年份:1995
-
负责人:Charles T. Lutz
-
依托单位:
国内基金
海外基金
登录
查看更多内容
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:32170319
-
项目类别:面上项目
-
资助金额:58.00万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
帽结合蛋白(cap binding protein)调控乙烯信号转导的分子机制
-
批准号:--
-
项目类别:--
-
资助金额:58万元
-
批准年份:2021
-
负责人:董春海
-
依托单位:
ID1 (Inhibitor of DNA binding 1) 在口蹄疫病毒感染中作用机制的研究
-
批准号:31672538
-
项目类别:面上项目
-
资助金额:62.0万元
-
批准年份:2016
-
负责人:孙跃峰
-
依托单位:
番茄EIN3-binding F-box蛋白2超表达诱导单性结实和果实成熟异常的机制研究
-
批准号:31372080
-
项目类别:面上项目
-
资助金额:80.0万元
-
批准年份:2013
-
负责人:杨迎伍
-
依托单位:
P53 binding protein 1 调控乳腺癌进展转移及化疗敏感性的机制研究
-
批准号:81172529
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2011
-
负责人:杨其峰
-
依托单位:
DBP(Vitamin D Binding Protein)在多发性硬化中的作用和相关机制的蛋白质组学研究
-
批准号:81070952
-
项目类别:面上项目
-
资助金额:35.0万元
-
批准年份:2010
-
负责人:刘师莲
-
依托单位:
研究EB1(End-Binding protein 1)的癌基因特性及作用机制
-
批准号:30672361
-
项目类别:面上项目
-
资助金额:24.0万元
-
批准年份:2006
-
负责人:徐宁志
-
依托单位: